Xenetic Biosciences Files 10-K/A Amendment
Ticker: XBIO · Form: 10-K/A · Filed: Apr 29, 2025 · CIK: 1534525
| Field | Detail |
|---|---|
| Company | Xenetic Biosciences, Inc. (XBIO) |
| Form Type | 10-K/A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, 10-K, governance
TL;DR
Xenetic Biosciences filed a 10-K/A amendment for FY24, updating Part III info on execs & ownership.
AI Summary
Xenetic Biosciences, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. This amendment specifically addresses Items 10-14 of Part III, which typically cover information about directors, executive officers, compensation, security ownership, and related party transactions. The filing was made on April 29, 2025.
Why It Matters
This amendment provides updated details on the company's governance, executive compensation, and shareholder information, which are crucial for investors to assess the company's leadership and potential conflicts of interest.
Risk Assessment
Risk Level: low — This filing is an amendment to a previous report and primarily contains updated procedural information rather than new material financial or operational disclosures.
Key Numbers
- 2024 — Fiscal Year End (The amendment pertains to the fiscal year ending December 31, 2024.)
- April 29, 2025 — Filing Date (The amendment was filed on this date.)
Key Players & Entities
- Xenetic Biosciences, Inc. (company) — Registrant
- 0001683168-25-002939 (filing_id) — Accession Number
- 20250429 (date) — Filing Date
- 20241231 (date) — Fiscal Year End
- 001-37937 (company_id) — Commission File Number
FAQ
What specific items are being amended in Part III of the 10-K?
The amendment explicitly states it is to include Items 10-14 of Part III.
What is the primary purpose of this 10-K/A filing?
The filing is Amendment No. 1 to the Form 10-K for the fiscal year ended December 31, 2024, to include Items 10-14 of Part III.
When was the original 10-K filed or expected to be filed?
While not explicitly stated, a 10-K/A indicates a prior 10-K filing or an expected filing that is being amended before finalization.
What is Xenetic Biosciences, Inc.'s SIC code?
The SIC code for Xenetic Biosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What was Xenetic Biosciences, Inc. formerly known as?
The company was formerly known as General Sales & Leasing, Inc. (name change effective February 27, 2013) and prior to that, GENERAL AIRCRAFT INC. (name change effective November 8, 2011).
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 29, 2025 regarding Xenetic Biosciences, Inc. (XBIO).